_____________________________________________________________________________________________________________ hVIVO infrastructure to deliver it. Equally, we’ re prioritizing the external communication of our integrated sales strategies, whilst also further expanding our cardiometabolic services and respiratory disease challenge models,” Andrew says, concluding our conversation excited for the opportunities ahead.
“ We’ re now in a steady growth phase where we can be a fully integrated partner and save more lives. Over the next five years, we hope to be a bigger, stronger, and more
diversified business and additionally wellestablished as a key service provider in the
respiratory disease market that targets new medicines for asthma and COPD.” ■
Transforming
the PCR experience
Fully integrated nanoplate-based digital PCR system
• Superior partitioning for high accuracy and sensitivity
• Advanced multiplexing for simultaneous multiple target detection
• Walk-away workflow automation for faster time to results
• Flexible and scalable instruments for various throughput needs
For more information visit www. qiagen. com / dPCR www. hvivo. com
Sample to Insight
manufacturing-today. com 85